A proposal to facilitate weight-of-evidence assessments: Harmonization of Neurodevelopmental Environmental Epidemiology Studies (HONEES)

Neurotoxicology and Teratology

Volumn 33, Issue 3, 2011, Pages 354-359

  Youngstrom, Eric ^a   Kenworthy, Lauren ^b   Lipkin, Paul H ^c   Goodman, Michael ^d   Squibb, Katherine ^e   Mattison, Donald R ^f   Anthony, Laura Gutermuth ^b   Makris, Susan L ^g   Bale, Ambuja S ^g   Raffaele, Kathleen C ^g   Lakind, Judy S ^e,h,i  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^g U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^h IPEX USA LLC   (United States)

ⁱ PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Environmental chemicals; Environmental epidemiology; Interstudy consistency; Neurodevelopmental function tests; Risk assessment; Weight of evidence assessments

Indexed keywords

ENVIRONMENTAL CHEMICAL; NEUROTOXIN;

ARTICLE; CHILD HEALTH; CLINICAL ASSESSMENT TOOL; CONSENSUS DEVELOPMENT; DIAGNOSTIC VALUE; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; HARMONIZATION OF NEURODEVELOPMENTAL ENVIRONMENTAL EPIDEMIOLOGY STUDIES; HEALTH HAZARD; HUMAN; INTERDISCIPLINARY RESEARCH; NEUROTOXICITY; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY CONTROL; STANDARD;

ANIMALS; BIOMEDICAL RESEARCH; DATA INTERPRETATION, STATISTICAL; ENVIRONMENTAL POLLUTANTS; FEMALE; GUIDELINES AS TOPIC; HUMANS; NERVOUS SYSTEM; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 79957841165     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2011.01.004     Document Type: Article

References (32)

1. Achenbach T.M., Rescorla L.A. Manual for the ASEBA adult forms & profiles 2003, University of Vermont, Burlington, VT.
2. Anthony L.G., Youngstrom E., Kenworthy L., Lakind J.S., Goodman M., Squibb K., et al. Threats to study validity: the Flynn Effect, examiner drift, confounders, lost in translation, and other important considerations. Neurotoxicol Teratol 2010, 32(NBTS36):506.
3. Bellinger D.C. Interpreting epidemiologic studies of developmental neurotoxicity: conceptual and analytic issues. Neurotoxicol Teratol 2009, 31:267-274.
4. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. Standards for reporting of diagnostic accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003, 326:41-44.
5. Campbell D.T., Stanley J.C. Experimental and quasi-experimental designs for research 1963, Houghton Mifflin, Boston.
6. Drotar D., Stein R.E.K., Perrin E.C. Methodological issues in using the Child Behavior Checklist and its related instruments in clinical child psychology research. Special Issue: Methodological issues in clinical child psychology research. J Clin Child Psychol 1995, 24:184-192.
7. Eubig P.A., Aguiar A., Schantz S.L. Lead and PCBs as risk factors for attention deficit hyperactivity disorder. Environ Health Perspect 2010, 10.1289/ehp.0901852.
8. Flynn J.R. Searching for justice: the discovery of IQ gains over time. Am Psychol 1999, 54:5-20.
9. Goodman M. Weight-of-the-evidence assessment in neurodevelopmental epidemiology: a plea for consistency. Neurotoxicol Teratol 2010, 32(NBTS37):507.
10. Goodman M., Squibb K., Youngstrom E., Anthony L.G., Kenworthy L., Lipkin P.H., et al. Using systematic reviews and meta-analyses to support regulatory decision making for neurotoxicants: lessons learned from a case study of PCBs. Environ Health Perspect 2010, 118:727-734.
11. Grandjean P., Landrigan P.J. Developmental neurotoxicity of industrial chemicals. Lancet 2006, 368:2167-2178.
12. Hoffman K., Webster T.F., Weisskopf M.G., Weinberg J., Vieira V.M. Exposure to polyfluoroalkyl chemicals and attention deficit hyperactivity disorder in U.S. children aged 12-15 Years. Environ Health Perspect 2010, Dec;118(12):1762--7.
13. Hollingworth W., Medina L., Lenkinski R.E., Shibata D.K., Bernal B., Zurakowski D., et al. Interrater reliability in assessing quality of diagnostic accuracy studies using the QUADAS tool. A preliminary assessment. Acad Radiol 2006, 13:803-810.
14. Hunsley J., Mash E.J. Introduction to the special section on developing guidelines for the evidence-based assessment (EBA) of adult disorders. Psychol Assess 2005, 17:251-255.
15. Hunsley J., Mash E.J. Developing criteria for evidence-based assessment: an introduction to assessments that work. A guide to assessments that work 2008, 3-16. Oxford University Press, New York. J. Hunsley, E.J. Mash (Eds.).
16. Kenworthy L., Anthony L.G., Goodman M., Lakind J.S., Lipkin P.H., Mattison D., et al. Getting the biggest bang for your buck: choosing neurodevelopmental tests that maximize power. Neurotoxicol Teratol 2010, 32(NBTS35):506.
17. Lakind J.S., Youngstrom E., Goodman M., Squibb K., Lipkin P.H., Anthony L.G., et al. A multidisciplinary approach to advancing the science of neurodevelopmental testing in cohorts of infants and young children. Neurotoxicol Teratol 2010, 32(NBTS 34):505.
18. Moher D., Schulz K.F., Simera I., Altman D.G. Guidance for developers of health research reporting guidelines. PLoS Med 2010, 7(2):e1000217.
19. Pastor P.N., Reuben C.A. Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004-2006. National Center for Health Statistics. Vital Health Stat 2008, 10(237):1-14. http://www.cdc.gov/nchs/data/series/sr_10/Sr10_237.pdf.
20. Plusquellec P., Muckle G., Dewailly E., Ayotte P., Bégin G., Desrosiers C., et al. The relation of environmental contaminants exposure to behavioral indicators in Inuit preschoolers in Arctic Quebec. Neurotoxicology 2010, 31:17-25.
21. Raffaele K., Rowland J., May B., Makris S., Schumacher K., Scarano L. The use of developmental neurotoxicity data in pesticide risk assessments. Neurotoxicol Teratol 2010, 32:563-572.
22. Rice C., Nicholas J., Baio J., Pettygrove S., Lee L.C., Braun K.V.N., et al. Changes in autism spectrum disorder prevalence in 4 areas of the United States. Disabil Health J 2010, 3:186-201.
23. Roberts E.M., English P.B., Grether J.K., Windham G.C., Somberg L., Wolff C. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ Health Perspect 2007, 115:1482-1489.
24. Straus S.E., Richardson W.S., Glasziou P., Haynes R.B. Evidence-based medicine: how to practice and teach EBM 2005, Churchill Livingstone, New York. 3rd ed.
25. Szyszkowicz M., Rowe B.H., Colman I. Air pollution and daily emergency department visits for depression. Int J Occup Med Environ Health 2009, 22:355-362.
26. U.S.EPA IRIS toxicological review of tetrachloroethylene (Perchlorethylene), external review draft 2008, U.S. Environmental Protection Agency, National Center for Environmental Assessment, Washington, DC. http://cfpub.epa.gov/ncea/iris_drafts/recordisplay.cfm?deid=192423.
27. U.S.EPA Integrated risk information system (IRIS) 2010, U.S. Environmental Protection Agency, National Center for Environmental Assessment, Washington, DC. http://http:/www.epa.gov/iris.
28. U.S.EPA IRIS toxicological review of trichloroethylene, external review draft 2010, U.S. Environmental Protection Agency, National Center for Environmental Assessment, Washington, DC. http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=215006.
29. von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008, 61:344-349.
30. Whiting P., Rutjes A.W., Reitsma J.B., Bossuyt P.M., Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25.
31. Whiting P.F., Weswood M.E., Rutjes A.W., Reitsma J.B., Bossuyt P.N., Kleijnen J. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 2006, 6:9.
32. Youngstrom E., Lakind J.S., Kenworthy L., Lipkin P.H., Goodman M., Squibb K., et al. Advancing the selection of neurodevelopmental measures in epidemiological studies of environmental chemical exposure and health effects. Int J Environ Res Public Health 2010, 7:229-268.